Investigation reveals immunostimulatory activity of peptidoglycan derivatives in THP-1 cells, suggesting potential as vaccine adjuvants.
To develop vaccine adjuvants from bacterial peptidoglycan (PG) the immunostimulatory activity of lysozyme‐solubilized PG derived from Levilactobacillus brevis and Lactiplantibacillus plantarum was investigated. Solubilized PG from both bacteria induced IL‐8 in THP‐1 cells, and periodate oxidation of L. plantarum PG reduced the activity, suggesting that muramyl dipeptide was partially destroyed. Periodate‐oxidized L. plantarum PG showed reduced IL‐8 inducing activity in NOD2‐expressing cells, while it remained in NOD1‐expressing cells, suggesting that γ‐ d ‐glutamyl‐ meso ‐diaminopimelic acid structure was maintained. All PG preparations stimulated RAW264.7 cells to proliferate, suggesting that they could be potent candidates for vaccine adjuvants.
No takes yet. Share an insight, caveat, or question.
Noguchi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: